Catalyst
Slingshot members are tracking this event:
Phase 3 data of VX-661 in patients with two Copies of the F508del mutation are expected by early 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VRTX | Community voting in process | |||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 28, 2017
Occurred Source:
http://investors.vrtx.com/releasedetail.cfm?ReleaseID=1019156
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 3 Data, Vx-661, F508del Mutation
